Unknown

Dataset Information

0

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.


ABSTRACT: Recent studies have demonstrated that acquisition of epithelial-to-mesenchymal transition (EMT) is associated with drug resistance in pancreatic cancer cells; however, the underlying mechanisms are not fully elucidated. Emerging evidence suggests that microRNAs play a crucial role in controlling EMT. The aims of this study were to explore the potential role of miR-223 in governing EMT in gemcitabine-resistant (GR) pancreatic cancer cells. To achieve this goal, real-time reverse transcription-PCR and western blot analysis were used to validate whether GR cells acquired EMT in AsPC-1 and PANC-1 cells. Invasion, migration, and detachment assays were performed to further identify the EMT characteristics in GR cells. The miR-223 inhibitor was used to determine its role in GR-induced EMT. We found that GR cells acquired EMT features, which obtained elongated fibroblastoid morphology, decreased expression of epithelial marker E-cadherin, and up-regulation of mesenchymal markers. Furthermore, we observed that GR cells are associated with high expression of miR-223. Notably, inhibition of miR-223 led to the reversal of EMT phenotype. More importantly, miR-223 governs GR-induced EMT in part due to down-regulation of its target Fbw7 and subsequent upregulation of Notch-1 in pancreatic cancer. Our study implied that down-regulation of miR-223 could be a novel therapy for pancreatic cancer.

SUBMITTER: Ma J 

PROVIDER: S-EPMC4359328 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Ma Jia J   Fang Binbin B   Zeng Fanpeng F   Ma Cong C   Pang Haijie H   Cheng Long L   Shi Ying Y   Wang Hui H   Yin Bin B   Xia Jun J   Wang Zhiwei Z  

Oncotarget 20150101 3


Recent studies have demonstrated that acquisition of epithelial-to-mesenchymal transition (EMT) is associated with drug resistance in pancreatic cancer cells; however, the underlying mechanisms are not fully elucidated. Emerging evidence suggests that microRNAs play a crucial role in controlling EMT. The aims of this study were to explore the potential role of miR-223 in governing EMT in gemcitabine-resistant (GR) pancreatic cancer cells. To achieve this goal, real-time reverse transcription-PCR  ...[more]

Similar Datasets

| S-EPMC9748633 | biostudies-literature
| S-EPMC5479822 | biostudies-literature
| S-EPMC8122772 | biostudies-literature
| S-EPMC6413274 | biostudies-literature
| S-EPMC2727571 | biostudies-literature
| S-EPMC5042001 | biostudies-literature
| S-EPMC6579980 | biostudies-literature
| S-EPMC5518097 | biostudies-literature
| S-EPMC8414380 | biostudies-literature
| S-EPMC4931147 | biostudies-literature